MARCA |
CÓDIGO |
DESCRIÇÃO |
INFO. TÉCNICAS |
APRESENT. |
VALOR |
COTAÇÃO |
USP |
1067781 |
Betamethasone Dipropionate Related Compound H |
|
- |
- |
|
USP |
1043524 |
Asparagine Related Compound A (10 mg) (2,2'-(3,6-dioxopiperazine-2,5-diyl)diacetamide) |
- |
- |
- |
|
USP |
1424109 |
Ãlcool Metilico |
|
- |
- |
|
USP |
1012772 |
Ãlcool Desidratado |
|
- |
- |
|
USP |
1012768 |
Ãlcool |
|
- |
- |
|
USP |
1000612 |
Acebutolol Related Compound A (20 mg) (N-(3-Acetyl-4-hydroxyphenyl)butyramide) |
|
|
- |
|
USP |
1000601 |
Acebutolol Hydrochloride (125 mg) |
|
|
- |
|
USP |
1000576 |
Acamprosate Related Compound B (20 mg) |
|
|
- |
|
USP |
1000565 |
Acamprosate Related Compound A (15 mg) (3-aminopropane-1-sulfonic acid) |
|
|
- |
|
USP |
1000554 |
Acamprosate Calcium (200 mg) |
|
|
- |
|
USP |
1000532 |
Acarbose System Suitability Mixture (2 mg) (COLD SHIPMENT REQUIRED) |
|
|
- |
|
USP |
1000521 |
Acarbose (200 mg) (COLD SHIPMENT REQUIRED) |
|
|
- |
|
USP |
1000500 |
Abacavir System Suitability Mixture (15 mg) (A mixture containing abacavir sulfate and trans-abacavir) |
|
|
- |
|
USP |
1000485 |
Abacavir Related Compounds Mixture (15 mg) |
|
|
- |
|
USP |
1000437 |
Abacavir Related Compound D (20 mg) (N6-Cyclopropyl-9-{(1R,4S)-4-[(2,5-diamino-6-chlorpyrimidin-4-yloxy)methyl] cyclopent-2-enyl}-9H-purine-2,6-diamin |
|
|
- |
|
USP |
1000408 |
Abacavir Sulfate (200 mg) |
|
|
- |
|
USP |
1000452 |
Abacavir Related Compound C (20 mg) ([(1S,4R)-4-(2-amino-6-chloro-9H-purin-9-yl)cyclopent-2-enyl]methanol hydrochloride) |
|
|
- |
|
USP |
1000420 |
Abacavir Related Compound A (20 mg) ([4-(2,6-diamino-9H-purin-9-yl)cyclopent-2-enyl]methanol) |
|
|
- |
|
USP |
1000419 |
Abacavir Sulfate Racemic (20 mg) (4-[2-amino-6-(cyclopropylamino)-9H-purin-9yl]-2-cyclopentene-1-methanol sulfate (2:1)) |
|
|
- |
|
USP |
1000496 |
Abacavir Stereoisomers Mixture (15 mg) |
|
|
- |
|
USP |
1000441 |
Abacavir Related Compound B (20 mg) ([4-(2,5-diamino-6-chloropyrimidin-4-ylamino)cyclopent-2-enyl]methanol) |
|
|
- |
|